What Are the Symptoms of Rodenticide Poisoning in Dogs?
Rodenticide poisoning in dogs commonly produces one of three symptom patterns—anticoagulant-induced bleeding, neurologic disturbance from neurotoxic baits, or metabolic and renal signs from vitamin D–based products—so clinical presentation depends on the active ingredient and the amount ingested. Anticoagulant rodenticides often lead to delayed bleeding, while bromethalin causes rapid-onset tremors, ataxia, and seizures, and cholecalciferol (vitamin D3) formulations produce vomiting, increased thirst and urination, weakness, and potential kidney injury; recognition requires knowing these toxin-specific syndromes as well as their typical time courses.
This issue is especially relevant to Pacific Northwest homeowners because the region’s mild, wet climate and abundant forested and riparian habitat support persistent rodent populations year-round, increasing the frequency of bait placement in and around homes, outbuildings, and agricultural sites. Dense urban–wildland interfaces, seasonal rodent movements, and historical use of potent second‑generation anticoagulants mean domestic dogs in this region face both primary exposures and secondary risks from contaminated prey, and veterinarians here routinely evaluate pets with subtly timed or nonspecific signs that can mask a rodenticide exposure.
What are the typical signs of anticoagulant rodenticide poisoning in dogs in the Pacific Northwest
Anticoagulant rodenticides interfere with vitamin K–dependent clotting factors, and the cardinal clinical feature in dogs is bleeding rather than immediate gastrointestinal distress. Expect mucosal pallor, petechiae and ecchymoses on the skin, prolonged bleeding from minor wounds, epistaxis, hematuria and melena; respiratory signs such as tachypnea or coughing indicate pulmonary hemorrhage, and abdominal distension or acute pain often reflects hemoabdomen. In the Puget Sound region these presentations commonly show up during the wet months (late fall through early spring) when both rodenticide use and outdoor dog activity near riparian corridors increase the chance of exposure.
On objective testing, anticoagulant intoxication typically produces a prolonged prothrombin time (PT) before platelet abnormalities appear: PT often rises to 1.5–3× an animal’s baseline by the time clinical bleeding is evident, while platelet count usually remains within reference intervals unless another process is present. Packed cell volume (PCV)/hematocrit will fall as hemorrhage progresses—mild cases may show PCV in the high-20s percent range, whereas severe hemoabdomen or pulmonary hemorrhage can drive PCV below 20%. Ultrasound frequently reveals free peritoneal or pleural fluid consistent with hemorrhage; radiographs may show pleural effusion or, less commonly, pulmonary infiltrates from blood.
The timing of clinical signs reflects both the mechanism and the compound involved. With coumarin-type anticoagulants the depletion of active clotting factors commonly delays overt bleeding for 36–72 hours after a single ingestion; clinically apparent hemorrhage most often appears 2–7 days post-exposure. Second-generation compounds used in many Seattle-area bait stations (brodifacoum, difenacoum, bromadiolone) are more potent and highly lipophilic, so coagulopathy can be more severe and persist longer—hepatic sequestration means protracted effects and documented persistence of anticoagulant activity for weeks. Because of that persistence, relapsing bleeding episodes are regularly reported in cases where exposure was to second-generation products.
Differential considerations in a bleeding dog in the Pacific Northwest include trauma from outdoor activity, rodent-borne infections that affect the liver, primary hepatic disease, and immune-mediated thrombocytopenia; key discriminators are a disproportionate prolongation of PT/aPTT with a normal platelet count and evidence of spontaneous internal bleeding without antecedent trauma. Complications to anticipate are severe anemia from ongoing hemorrhage, hemoabdomen with hypovolemia and shock, pulmonary hemorrhage with respiratory compromise, and intracranial hemorrhage producing neurological signs—once significant internal bleeding begins, cardiovascular collapse can occur within hours, whereas chronic low-grade bleeding may produce lethargy and exercise intolerance over weeks.
How do symptoms of bromethalin and cholecalciferol rodenticide poisoning differ in Seattle-area dogs
Bromethalin and cholecalciferol produce fundamentally different pathophysiology and therefore distinct clinical pictures. Bromethalin is a lipophilic neurotoxin that uncouples oxidative phosphorylation in CNS cells, producing intracellular swelling and increased intracranial pressure; clinical signs from high-dose exposures commonly appear within 4–36 hours and, with lower-dose or repeated exposures, onset can be delayed up to 3–5 days. Cholecalciferol (vitamin D3) is metabolized to calcitriol, causing marked increases in intestinal calcium absorption and bone resorption; measurable hypercalcemia usually develops within 24–72 hours, often peaks at 36–96 hours, and in some cases signs are not apparent until 2–7 days after ingestion.
The outward signs a dog exhibits map closely to those mechanisms. Bromethalin toxicity typically starts with hyperexcitability, tremors or hyperesthesia and progresses to ataxia, hind‑limb paresis (or an extensor‑rigid gait), proprioceptive deficits, blindness, debilitating seizures and rapid decline to coma and respiratory compromise in severe cases. By contrast, cholecalciferol initially produces gastrointestinal and polyuric–polydipsic signs — vomiting, anorexia, constipation, polyuria/polydipsia — followed by lethargy, dehydration, muscle weakness and signs of acute kidney injury (decreased urine concentration, oliguria) as BUN and creatinine rise; cardiac arrhythmias and neurologic signs (weakness, tremors, seizures) typically reflect secondary severe hypercalcemia rather than a primary CNS toxin. In practice, a dog with acute neuro deficits and minimal GI signs points toward bromethalin, whereas a dog with prominent vomiting, increased drinking/urination and laboratory hypercalcemia points toward cholecalciferol.
Diagnostic patterns differ in ways that are clinically useful. There is no widely available routine blood biomarker for bromethalin; diagnosis relies on a compatible exposure history and progressive neurological exam findings, and advanced imaging (MRI/CT) may show diffuse cerebral edema — specialized toxicology labs can detect bromethalin residues in serum or tissues but turnaround is slow. Cholecalciferol produces characteristic, measurable laboratory abnormalities: total serum calcium often rises above the normal canine range (normal ~9.0–11.5 mg/dL) and becomes concerning when >14 mg/dL, ionized calcium frequently exceeds ~1.6 mmol/L, phosphorus may be elevated initially, and BUN/creatinine increase as renal damage develops; a calcium × phosphorus product above ~70 mg^2/dL^2 is associated with risk of soft‑tissue mineralization. In Seattle, where indoor baiting and basement/garage use of rodenticides are common due to the damp climate, owners often lack a witnessed ingestion history, so pairing neuro signs with absence of hypercalcemia or finding high calcium despite minimal neuro deficits can help distinguish the two toxidromes.
Prognosis and likely clinical course diverge. Bromethalin carries a guarded to poor prognosis once marked CNS signs (refractory seizures, coma) are present; death often occurs within 24–72 hours of severe neurologic progression, and survivors can retain persistent deficits. Cholecalciferol outcomes depend heavily on the magnitude and duration of hypercalcemia and whether renal injury has already occurred: dogs whose total calcium remains below roughly 16 mg/dL and who have no significant creatinine rise have substantially better chances of renal recovery, while prolonged hypercalcemia (>48–72 hours) or a Ca × P product exceeding about 70 markedly increases the risk of irreversible soft‑tissue mineralization and poorer long‑term outcome. Seasonal and urban factors in the Pacific Northwest — increased indoor rodent activity in cool, wet months and greater use of professional and consumer rodenticides — mean local practitioners see both presentations year‑round, sometimes with delayed presentations when nocturnal rodent feeding or hidden bait stations in damp crawlspaces delay owner detection.
How quickly do symptoms appear after ingestion and how long can onset be delayed in Pacific Northwest dogs
Anticoagulant rodenticides show a class-dependent delay: first‑generation compounds (warfarin, chlorophacinone) usually produce measurable coagulopathy and visible bleeding 48–96 hours after ingestion, with most clinical hemorrhages occurring on days 3–5. Second‑generation anticoagulants (brodifacoum, difenacoum, bromadiolone) are far more potent and can cause coagulopathy 2–7 days after a single ingestion; because these compounds are sequestered in the liver and have very long half‑lives, abnormal clotting times and risk of rebleeding can persist or recur over a period of weeks (commonly 2–4 weeks, and occasionally longer).
Bromethalin produces neurologic signs in a dose‑dependent, generally faster timeline than anticoagulants. High, single‑dose ingestions commonly generate tremors, hyperexcitability, ataxia and progressing hind‑limb paresis or seizures within 4–36 hours; lower, subacute exposures often present between 24 hours and 7 days, and in some low‑dose cases clinical deterioration has been reported up to 10–14 days after exposure. Because bromethalin acts as a mitochondrial uncoupler causing rapid cerebral edema and raised intracranial pressure, onset and severity correlate closely with the ingested dose (grams per kilogram), formulation (paste versus wax block) and whether the dog had concurrent food in the stomach.
Cholecalciferol (vitamin D3) formulations produce a characteristic biochemical delay: serum total calcium in dogs normally runs about 9.0–11.5 mg/dL; with cholecalciferol ingestion serum calcium typically begins to rise within 24–72 hours and often exceeds 14 mg/dL by 48–96 hours in clinically affected animals. Clinical signs tied to hypercalcemia (vomiting, polyuria/polydipsia, weakness) commonly appear 2–4 days post‑ingestion, while azotemia and renal cortical injury from calcium deposition often develop 3–7 days later; the biochemical disturbance can persist for one to several weeks as vitamin D metabolites redistribute and are eliminated.
Local and exposure variables in the Pacific Northwest influence these timelines. Cool, humid Seattle conditions can preserve bait palatability in sheltered locations (garages, crawlspaces), increasing the chance of staggered or repeated ingestion and producing a more protracted onset curve; indoor rodent infestations that peak in fall/winter raise the likelihood of single large ingestions or secondary exposures from poisoned prey. Secondary poisoning (a dog eating a poisoned rodent) commonly delivers a lower, less predictable dose than direct bait consumption—onset for second‑generation anticoagulants after secondary ingestion frequently mirrors primary exposure (several days) but can be more variable and sometimes delayed, depending on residue levels in the carcass and the dog’s body weight and metabolic status.
How common is secondary poisoning from poisoned rodents and wildlife in the Pacific Northwest and what increases a dog’s risk
Urban and peri‑urban monitoring studies across North America, including the Pacific Northwest, routinely detect anticoagulant rodenticide residues in 30–80% of sampled raptors and mesopredators, indicating that poisoned prey are widespread in city environments. Those residue surveys do not translate directly to clinical canine cases but demonstrate an environmental reservoir: predators and scavengers that frequent backyards and greenbelts around Seattle commonly carry measurable levels of second‑generation anticoagulants, so opportunities for a dog to encounter a poisoned carcass are regular in built environments.
The chemical class of the bait strongly affects secondary‑poisoning risk. Second‑generation anticoagulants (brodifacoum, difenacoum, bromadiolone, difethialone) are lipophilic and concentrate in liver and fat; hepatic residues in poisoned rodents can persist for weeks to months, so a single eaten rodent can deliver a clinically relevant dose to a small dog. First‑generation agents (warfarin, chlorophacinone, diphacinone) have shorter tissue persistence measured in days and are comparatively less likely to cause secondary exposure. Bromethalin and cholecalciferol produce different risks: bromethalin is acutely neurotoxic and does not concentrate long‑term in liver like SGARs—secondary poisoning is less frequently documented but still possible if a dog consumes multiple intoxicated prey—whereas cholecalciferol’s metabolites cause hypercalcemia and are less prone to accumulating in prey tissues at levels that reliably produce secondary effects.
Local ecology and seasonality in the Seattle area create specific exposure pathways. Commensal species (Norway rats, house mice, deer mice/voles) are abundant year‑round in the city because mild, wet winters and ubiquitous shelter (basements, under decks, greenbelt brush) allow continuous reproduction; anticoagulant‑poisoned rodents often die 2–7 days after ingestion, leaving carcasses accessible to raccoons, opossums, crows and raptors such as Cooper’s and red‑tailed hawks. These urban scavengers and raptors then carry residues into neighborhoods; dogs that find carcasses in alleys, under porches, or at the edges of parks are at measurable risk, especially during fall–winter rodent control campaigns when baiting intensity typically increases.
Dog‑level risk modifiers are predictable and quantifiable: body weight, prey‑handling behavior, and outdoor access. Small dogs (under ~10 kg) require a smaller absolute dose to reach toxicity, so ingestion of a single poisoned rat has been implicated in clinical anticoagulant toxicity in small breeds; terriers, hounds and other breeds that kill and eat rodents are overrepresented in secondary‑poisoning case reports. Frequency of exposure matters — a dog that scavenges multiple carcasses over several days can accumulate a toxic dose even from prey with modest residues. Finally, dogs that spend time in alleyways, commercial districts, construction sites or near riparian corridors (where urban rodents and their predators concentrate) face higher odds of encountering poisoned wildlife than strictly indoor or leashed dogs in low‑rodent residential blocks.
What are the signs my dog ate rat poison?
Rodenticide poisoning typically produces one of three patterns: anticoagulant-induced bleeding (mucosal pallor, petechiae/ecchymoses, prolonged bleeding, hematuria or melena), neurologic signs from bromethalin (tremors, hyperexcitability, ataxia, seizures, hind‑limb paresis, rapid decline), or vitamin D–based cholecalciferol effects (vomiting, anorexia, polyuria/polydipsia, weakness and later signs of kidney injury). Which signs appear depends on the active ingredient and the dose ingested.
How long after ingesting rodenticide will my dog show symptoms?
It varies by class: first‑generation anticoagulants typically produce bleeding in about 48–96 hours, while second‑generation anticoagulants usually cause coagulopathy 2–7 days after a single ingestion and can persist or recur for weeks. Bromethalin neurologic signs often appear within 4–36 hours for high doses (but can be delayed several days with low doses), and cholecalciferol typically causes rising calcium within 24–72 hours with clinical hypercalcemia and renal signs appearing over 2–7 days.
Can my dog get poisoned by eating a poisoned rodent?
Yes — secondary poisoning is common with second‑generation anticoagulants because they concentrate in the liver and fat of poisoned rodents and can persist for weeks to months, so a dog eating one contaminated carcass can receive a clinically relevant dose, especially if it is small. First‑generation anticoagulants are less likely to cause secondary toxicity, while secondary risk from bromethalin and cholecalciferol is lower but still possible depending on residue levels and the amount consumed.
How can a veterinarian tell what type of rodenticide poisoned my dog?
Veterinarians use the clinical syndrome, timing and targeted laboratory tests: a disproportionately prolonged PT/aPTT with normal platelets points to anticoagulants, marked hypercalcemia with rising BUN/creatinine indicates cholecalciferol, and a progressive neurologic picture with compatible exposure suggests bromethalin (advanced imaging or specialized toxicology can support diagnosis). Because specific assays have slow turnaround, treatment decisions are often based on exposure history, the pattern of clinical signs and routine lab abnormalities.